Interestingly, CDK4 expression was not elevated in lenvatinib-resistant HCC cells and lenvatinib-resistant HCC xenograft tumor compared to the corresponding mock controls (Fig. 1h, Supplementary Fig. 2). The gene discussed is CDK4; the disease is neoplasm.